[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
作者信息
Wang Z M, Song Y
出版信息
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.
Abstract
摘要
相似文献
1
[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].[免疫检查点抑制剂在肺癌中的作用：从临床试验到临床实践]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.
2
[Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].[非小细胞肺癌中免疫检查点抑制剂的预测生物标志物]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):87-91. doi: 10.3760/cma.j.issn.1001-0939.2020.02.004.
3
Recent clinical trials of immunotherapy in non-small-cell lung cancer.近期非小细胞肺癌免疫疗法的临床试验。
Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.
4
The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.联合免疫疗法作为非小细胞肺癌一线治疗方法的应用。
Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16.
5
Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.中国肺癌的回顾与展望：免疫检查点抑制剂的临床进展。
Oncologist. 2019 Feb;24(Suppl 1):S21-S30. doi: 10.1634/theoncologist.2019-IO-S1-s02.
6
[Immuno-checkpoint inhibitor resistance and strategy in lung cancer].[肺癌中的免疫检查点抑制剂耐药性及策略]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jul 12;43(7):603-606. doi: 10.3760/cma.j.cn112147-20200312-00319.
7
The estrogen pathway as a modulator of response to immunotherapy.雌激素通路作为免疫治疗反应的调节剂。
Immunotherapy. 2019 Sep;11(13):1161-1176. doi: 10.2217/imt-2019-0024. Epub 2019 Jul 30.
8
Principles of Immunotherapy in Non-Small Cell Lung Cancer.非小细胞肺癌的免疫治疗原则。
Thorac Surg Clin. 2020 May;30(2):187-198. doi: 10.1016/j.thorsurg.2020.01.009.
9
Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.基于证据的医学在非小细胞肺癌免疫治疗中的进展。
J Evid Based Med. 2018 Nov;11(4):278-287. doi: 10.1111/jebm.12322. Epub 2018 Nov 16.
10
Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?当前检查点抑制剂在治疗晚期和/或转移性肺癌中的应用：免疫疗法是否会超越化疗？
Curr Probl Cancer. 2019 Feb;43(1):43-53. doi: 10.1016/j.currproblcancer.2018.07.008. Epub 2018 Aug 4.
Zotero 插件